Literature DB >> 24500387

Efficacy of cyclosporine A for steroid-resistant severe Henoch-Schönlein purpura nephritis.

Shinichiro Ohara, Yukihiko Kawasaki, Kyohei Miyazaki, Atsushi Ono, Yuichi Suzuki, Kazuhide Suyama, Mitsuaki Hosoya.   

Abstract

Aggressive treatment is necessary for continuous high-range proteinuria in cases of pediatric Henoch-Schönlein purpura nephritis (HSPN) as the long-term prognosis is sometimes poor. Cyclosporine (CyA) has immunosuppressive effects as well as a very selective inhibitory effect on T-helper cell function. Here we report two 7-year-old boys with steroid-resistant HSPN treated with CyA. After diagnosis of HSPN, we treated both patients with methylprednisolone and urokinase pulse therapy (MUT) combined with multiple drugs; however, high-range proteinuria persisted and CyA was added to the treatment regimen. The proteinuria subsequently decreased gradually and pathological findings at the second renal biopsy were improved. Furthermore, neither patient showed any adverse effects, such as hypertension, encephalopathy, or chronic nephrotoxicity, to the CyA treatment.In conclusion, these results suggest that CyA may be a safe and effective treatment for steroid-resistant severe HSPN.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24500387     DOI: 10.5387/fms.59.102

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  4 in total

Review 1.  Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature.

Authors:  Roberta Fenoglio; Carla Naretto; Bruno Basolo; Giacomo Quattrocchio; Michela Ferro; Paola Mesiano; Giulietta Beltrame; Dario Roccatello
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  Treatment of Henoch Schonlein nephritis; new trends.

Authors:  Azar Nickavar
Journal:  J Nephropathol       Date:  2016-07-28

Review 3.  Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis.

Authors:  Xuerong Yang; Qi Li; Yuanyuan He; Yulian Zhu; Rou Yang; Xiaoshi Zhu; Xi Zheng; Wei Xiong; Yong Yang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 4.  Childhood Vasculitis.

Authors:  Anja Schnabel; Christian M Hedrich
Journal:  Front Pediatr       Date:  2019-01-10       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.